Kalium-Natrium-Glucose Braun

Glucose, the active ingredient in Kalium-Natrium-Glucose Braun, is a IV electrolyte and glucose solution presented as an injection solution for intravenous use. It provides water, electrolytes and glucose to restore fluid balance, correct electrolyte disturbances and supply energy to patients requiring fluid and electrolyte replacement.

GNH USA supplies Kalium-Natrium-Glucose Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Kalium‑Natrium‑Glucose Braun is used in clinical situations that require intravenous fluid, electrolyte and glucose support.

- Fluid and electrolyte replacement: restores plasma volume and corrects deficits of potassium and sodium. - Hypoglycemia: provides rapid glucose to raise blood sugar in acute low‑glucose states. - Maintenance of plasma volume: sustains intravascular volume during surgery or trauma.

Common Side Effects: - Injection site pain or erythema. - Mild hyperkalemia. - Mild hypernatremia. - Transient hyperglycemia. - Phlebitis. - Minor electrolyte imbalance.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Severe hypernatremia causing neurological symptoms. - Anaphylactic or severe hypersensitivity reaction. - Volume overload with pulmonary edema. - Severe hypoglycemia if glucose is not required. - Cardiac arrest due to electrolyte disturbances.

Before administration, evaluate the patient's electrolyte status and cardiac function. - Assess serum potassium and sodium levels: adjust infusion rate based on results. - Monitor cardiac rhythm: especially in patients with known arrhythmias. - Adjust dosage in renal impairment: reduced clearance may increase electrolyte levels. - Avoid rapid infusion in heart‑failure patients: risk of volume overload. - Use aseptic technique: prevent contamination of the IV line. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Kalium‑Natrium‑Glucose Braun may interact with several medications.

Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: increased risk of hyperkalemia. - Co‑administration with hypertonic saline: additive electrolyte overload. - Simultaneous high‑dose insulin therapy: rapid intracellular potassium shift.

Moderate Interactions (Monitor Closely): - Loop diuretics: may cause electrolyte depletion requiring monitoring. - ACE inhibitors or ARBs: can raise potassium levels. - Beta‑blockers: may mask hypoglycemia symptoms, requiring close observation.